Last reviewed · How we verify
NCT07252128: BDAS-HP
Effectiveness of Brain Dynamic Audio Stimulation for Improving Insomnia and Sleep Cycles in Healthcare Professionals: A Pilot Study
NA trial testing Brain Dynamic Audio Stimulation in Sleep Disturbances and Insomnia in 15 participants. Enrolling by invitation.
31 March 2026
Quick facts
| Lead sponsor | Chi Mei Medical Hospital |
|---|---|
| Phase | NA |
| Status | ENROLLING BY INVITATION |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 15 |
| Start date | 14 August 2025 |
| Primary completion | 31 March 2026 |
| Estimated completion | 31 May 2026 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- Brain Dynamic Audio Stimulation
Conditions studied
- Sleep Disturbances and Insomnia — all drugs for Sleep Disturbances and Insomnia →
Sponsor
Chi Mei Medical Hospital
Who can join
Adults 20 to 65, any sex, with Sleep Disturbances and Insomnia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to evaluate the effectiveness of Brain Dynamic Audio Stimulation (BDAS) in improving sleep quality among healthcare professionals experiencing insomnia. Healthcare workers are frequently exposed to high occupational stress, irregular work schedules, and sleep disturbances, which may adversely affect mental well-being, cognitive performance, and clinical care. Participants will use BDAS once daily for 30 minutes over a two-week period under standardized conditions. Both subjective and objective sleep-related outcomes will be assessed. Subjective sleep quality will be evaluated using the Insomnia Severity Index (ISI). Objective sleep parameters will be derived from short-duration EEG-based sleep recordings, including measures of sleep onset, sleep efficiency, and sleep stage distribution based on standardized scoring criteria. This study seeks to determine whether audio-based neural entrainment through BDAS can facilitate sleep initiation and improve sleep efficiency in a real-world healthcare setting. As a non-pharmacological and non-invasive intervention, BDAS may offer healthcare professionals a safe and practical approach to managing insomnia and supporting overall well-being.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07252128
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sleep Disturbances and Insomnia
Currently open trials in the same condition.
- NCT06685965 — A Study to Evaluate Effects on Sleep and Safety of RE03 in PTSD Patients With Sleep Disturbances · Phase 2 · recruiting
Other Chi Mei Medical Hospital trials
Trials by the same sponsor.
- NCT05136573 — Exercises on CIPN, Fatigue, and Quality of Life in Colon Cancer Patients Receiving Chemotherapy · NA · unknown
- NCT05190055 — Evaluation of Treatment Effect of Minimally Invasive Spinal Fusion Surgery · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07252128 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Chi Mei Medical Hospital
- Last refreshed: 10 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07252128.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing